Search
Fosaprepitant
go.drugbank.com/drugs/DB06717ApprovedInvestigationalFosaprepitant is an intravenously administered antiemetic drug. It is a prodrug of Aprepitant.
Categories: Substance P/Neurokinin-1 Receptor Antagonist, Neurokinin 1 AntagonistsProducts: BRIAN EX, APRITANT IV® 150 MG POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLESurovatamig
go.drugbank.com/drugs/DB19420InvestigationalTNB-486 is under investigation in clinical trial NCT06564038 (A Study of AZD0486 Monotherapy or in Combination With Other Anti-cancer Agents for Mature B-cell Malignancies).
Synonyms: a) CH2 L92, G4v5 h P10, G4v4 CH2 A1.3, A1.2, G4v32 CH, H-gamma4 heavy chain anti-CD3D/CD3E dimer, Homo sapiens (1-450) [VH (Homo sapiens IGHV3-9*01 (100%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.8.16] (26-33.51-58.97-112)) (1-123)-Homo sapiens IGHG4*01 nG4m(Anvatabart opadotin
go.drugbank.com/drugs/DB18290InvestigationalSynonyms: ; conjugated at two engineered sites via a stable, F (pAF) (121), K120 (217) (121- 218), hinge 1-15 (219KB3305
go.drugbank.com/drugs/DB06349ExperimentalKB3305 is an investigational liver selective antagonist for the glucocorticoid receptor, developed by Karo Bio for the treatment of Type 2 Diabetes.
Synonyms: (4R)-4-((3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-7,12-DIHYDROXY-3-(2-(4-((8S,11R,13S,14S,17S)-17-HYDROXY-13-METHYL-3-OXO-17-PROP-1-YNYL-1,2,6,7,8,11,12,14,15,16-DECAHYDROCYCLOPENTA(A)PHENANTHREN-11-YL)-N-METHYL-ANILINO, 3.BETA.,5.BETA.,7.ALPHA.,12.ALPHA.)-7,12-DIHYDROXY-3-(2-((4-((11.BETA.,17.BETA.)-17-HYDROXY-3-OXO-17-(1-PROPYN-1-YL)ESTRA-4,9-DIEN-11-YL)PHENYL)METHYLAMINO)ETHOXY)CHOLAN-24-OIC ACIDEstradiol valerate
go.drugbank.com/drugs/DB13956ApprovedInvestigationalVet approvedAs a pro-drug of estradiol, estradiol acetate therefore has the same downstream effects within the body through binding to the Estrogen Receptor (ER) including ERα and ERβ subtypes, which are located in … Estradiol is the most potent form of all mammalian estrogenic steroids and acts as the major female sex hormone.
Mixtures: AI PROFAMILIA, DIVICONT TABLETAS 1 MG/5 MGCategories: P-glycoprotein substrates, Cytochrome P-450 SubstratesBiliverdin reductase A
go.drugbank.com/bio_entities/BE0000741TargetEnzymeHumansReduces the gamma-methene bridge of the open tetrapyrrole, biliverdin IXalpha, to bilirubin with the concomitant oxidation of a NADH or NADPH cofactor (PubMed:10858451, PubMed:7929092, PubMed:8424666,
Polypeptides: Biliverdin reductase ASynonyms: BVR AApolipoprotein A-II
go.drugbank.com/bio_entities/BE0000922TargetHumansMay stabilize HDL (high density lipoprotein) structure by its association with lipids, and affect the HDL metabolism
Polypeptides: Apolipoprotein A-IIThromboxane-A synthase
go.drugbank.com/bio_entities/BE0001893TargetHumansCatalyzes the conversion of prostaglandin H2 (PGH2) to thromboxane A2 (TXA2), a potent inducer of blood vessel constriction and platelet aggregation (PubMed:11097184, PubMed:11297515, PubMed:22735388, … Also cleaves PGH2 to 12-hydroxy-heptadecatrienoicacid (12-HHT) and malondialdehyde, which is known to act as a mediator of DNA damage. 12-HHT and malondialdehyde are formed stoichiometrically in the same
Polypeptides: Thromboxane-A synthaseAlpha-galactosidase A
go.drugbank.com/bio_entities/BE0002422TargetEnzymeHumansCatalyzes the hydrolysis of glycosphingolipids and participates in their degradation in the lysosome
Polypeptides: Alpha-galactosidase ASynonyms: Alpha-D-galactosidase ASurface protein A
go.drugbank.com/bio_entities/BE0002809TargetNeisseria meningitidisPolypeptides: Surface protein A